StreetAccount Summary - Trading higher/lower: EU mid-morning
SCHOTT Pharma downgraded to neutral from buy at UBS (€21.75, 0.00)
SCHOTT Pharma downgraded to sector perform from outperform at RBC Capital Markets (€23.35, 0.00)
SCHOTT Pharma considering an IPO of its Indian business - Bloomberg (pre-EU open) (€25.00, 0.00)
SCHOTT Pharma downgraded to hold from buy at Deutsche Bank (€24.65, 0.00)
SCHOTT Pharma initiated overweight at JPMorgan (€22.60, 0.00)
SCHOTT Pharma upgraded to overweight from equal weight at Barclays (€21.60, 0.00)
Powered by FactSet Research Systems Inc.